recent post

Counterfeit drugs remain a challenge for pharma companies-Suresh Subramanian, National Lifesciences Leader, EY Parthenon India

December 5, 2024
recent post

Automation in Action: How Tech is Revolutionising Clinical Diagnostics in India

recent post

Bajaj Finserv AMC launches Bajaj Finserv Healthcare Fund

recent post

ENTOD Pharmaceuticals ropes in Dr Anish Desai as Scientific & Research Adviser 

recent post

LPU's International Conference of Pharmacy 2024 discuss ways to transform pharma landscape

CSMIA launches rapid COVID testing facility

CSMIA launches rapid COVID testing facility

International passengers will get the test reports in flat 13 minutes Chhatrapati Shivaji Maharaj International Airport (CSMIA), introduced a unique technology that provides results for COVID-19 in just 13 minutes. The testing facility option is available for all international arriving passengers at the airport. The 24 x 7 testing facility is located at Level 2 near exit Gate B.  In compliance with the Indian Council of Medical Research (ICMR) standards, CSMIA is the first airport to adopt the express test method by Abbott ‘ID Now’. The express test is available at Rs 4500 and aims to provide arriving passengers with quick and accurate diagnosis in 13 minutes. Passengers can also opt for regular RT-PCR test which takes around six to eight hours for the result.  The rapid molecular testing technology by Abbott is a tool to help fight the pandemic by allowing fast, highly sensitive and accurate diagnosis. Reducing the wait time for reports and provides early detection of the virus in time for passengers to take necessary measures to prevent disease transmission. Thus, creating a safer environment for travellers and airport staff. This facility was launched recently by the airport and since the commencement of this test, CSMIA has witnessed an average of 30-35 tests per day and a total of 400 passengers as of 28 December; these include those who had connecting flights to destinations outside Maharashtra.